Define Ventures is the one of the largest funds focused on early-stage health tech companies. With $800 AUM, we take a high conviction approach in partnering with companies at the earliest stages.
We believe the future of healthcare will be defined who bring together a deep understanding of the healthcare ecosystem paired with a technology-driven mindset. Our team was built in this vision, bringing together founders and investors who built category-defining companies and delivered $23 billion in exit value including Livongo (LVGO), Hims & Hers (NYSE: HIMS), Evolent (NYSE: EVH), and Advisory Board (NASDAQ: ABCO).
Our founders, strategic partners, and LPs choose to partner with us because we pull the full weight of our network and expertise to play offense and drive results. For example, over half of our partner companies have customers from our coalition of large health systems, health plans, employers, and life sciences companies.
We only partner with those who bring a principled approach to building impactful, category-defining companies and we hold ourselves to the same standards.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Investing team
Chirag ShahPartner
Chuka EsiobuPrincipal
Garrett HowardPrincipal
Hong TruongPrincipal
Lynne Chou O'KeefeFounder & Managing Partner
Michael WertPartner
How to reach them
Warm intro
Notable investments
Hims & Hers, FOLX Health, Cohere Health, Centivo, Unite Us, Tia, Concert Health, Waltz Health